NovAccess Global Inc. (XSNX)
OTCMKTS · Delayed Price · Currency is USD
0.0005
+0.0004 (400.00%)
Jan 22, 2026, 9:30 AM EST
NovAccess Global Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
2
Market Cap
30.95K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | - | - | - |
| Sep 30, 2023 | - | - | - |
| Sep 30, 2022 | - | - | - |
| Sep 30, 2021 | - | - | - |
| Sep 30, 2020 | - | - | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Gelesis Holdings | 12.14M |
| Hard to Treat Diseases | 6.16M |
| Statera Biopharma | 3.69M |
| Kaleido Biosciences | 1.10M |
| MultiCell Technologies | 805.24K |
| Theralink Technologies | 635.45K |
| Syros Pharmaceuticals | 386.00K |
| Therapeutic Solutions International | 85.32K |
NovAccess Global News
- 1 year ago - NovAccess Global Advisory on Annual Meeting of Shareholders - Accesswire
- 1 year ago - NovAccess Global Announces New License to Advance its Immunotherapy Platform - Accesswire
- 2 years ago - NovAccess Global Provides Business Updates and Announces Scheduling of Annual Meeting of Shareholders - Accesswire
- 2 years ago - NovAccess Global Announces $10.7 Million Financing - Accesswire
- 2 years ago - NovAccess Global Inc. to Present at the December 7th Virtual Investor Summit - Newsfile Corp
- 2 years ago - NovAccess Global Appoints Dr. Roscoe M. Moore, Jr. to Scientific Advisory Board - Accesswire
- 2 years ago - NovAccess Global Partners with BCN Biosciences to Expand Immunotherapy Platform - Accesswire
- 2 years ago - NovAccess Global to Participate in National Brain Tumor Society's Annual Glioblastoma Awareness Day - Accesswire